Welcome : Guest

Pfizer Ltd. (India) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Pfizer Ltd., which is principally involved in Pharmaceutical Products Business. Illustrated with 324 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-07001
Price: $3500
Company Type: Public
Pages: 330
Date: January 2017
Market Data Tables: 324

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Pfizer Ltd.'s (Operations) Sales by Product Segment (2015-2016) in ₹ Lakhs for Liquid Parenterals, Tablets and Capsules, Powder Parenterals, Liquids, Solids, Cosmetics and Toiletries - Liquid and Lotions, and Ointments......6
Infectious Disease Drugs......7
Table 2: Infectious Disease Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Molecular Diagnostics Infectious Diseases, and Others......7
Table 3: Infectious Disease Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Antifungals, Antivirals, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......8
Specialty Pharma & Orphan Drugs......9
Table 4: Specialty Pharma & Orphan Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, US and Rest of the World......9
Urinary Incontinence Drugs......10
Table 5: Urinary Incontinence Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Detrol, Detrol LA (PFE), Newer Therapies (ACT, AGN, PFE), Oxybutinin, and Others (Generics)......10
Table 6: Urinary Incontinence Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anticholinergic Agents, and Newer Therapies......11
Pain Drugs......12
Table 7: Pain Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Fentanyl, Hydrocordone, Acetaminophen, Lidoderm, Lyrica, OpanaER, Oxycotin, and Others......12
Central Nervous System (CNS) Drugs......13
Table 8: Central Nervous System (CNS) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......13
Table 9: Central Nervous System Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI’s, Tranquilizers, and Others......14
Women's Health Drugs......15
Table 10: Women's Health Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Contraceptives, Hormone Therapy, Fertility, and Others......15
Vaccines......16
Table 11: Vaccines Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Adult Prophylactic Vaccines (USD 8.5bn), Pediatric Vaccines (USD 16.7bn) and Others......16
Respiratory Drugs......17
Table 12: Respiratory Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue, and Rhinitis......17
Table 13: Respiratory Therapeutic Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue and Rhinitis......18
Cardiology Therapeutics......19
Table 14: Cardiovascular Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......19
Table 15: Cardiology Market by Category in the US (2015) - Percentage Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Anti-Arrhythmics, ARB's, Beta Blockers, Calcium Blockers, Cholesterol, Digitalis, Diuretics, Vasodilators, and Others......20
Table 16: Cardiology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cardiac Rhythm Management & Congestive Heart Failure Devices, Cardiac Surgery, and Interventional Cardiology......21
Antibiotics......22
Table 17: Antibiotics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......22
Table 18: Methicillin-Resistant Staphylococcus Aureus (MRSA) Antibiotics Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cubicin, Tygacil, Vancocin (Generic), Vibativ (Telavancin), and Zyvox......23
Table 19: Antibiotics Market by Category in China (2015) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......24
Table 20: Antibiotic Market by Drug Type in the US (2015) - Percentage Share Breakdown by Podiatrists Prescription for Cephalosporins, Macrolides, Penicillins, Quinolones, and Tetracyclines......25
Allergy Drugs......26
Table 21: Allergy and Rhinitis Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Allegra and Telfast, Avamys and Veramyst, Claritin and Clarinex, Zyrtec and Xyzal, and Others......26
Table 22: Allergy Care Market by Category in the US (2015) - Percentage Share Breakdown by Value for Private-Label and Others......27
Table 23: US Market (Private Label and Others) by Product (2015) - Percentage Share Breakdown by Values Sales for Allergy Care, Baby Food, Bakery, Bleach, Dairy, Deodorants, Hair Care, Ice Cream, Laundry Care, Oral Care, OTC, Pet Food, Pet Products, Retail Tissue, Sauces/Dressing, Skin Care, Sun Care, Toilet Care and VDS......28
Analgesic Molecules......29
Table 24: Analgesic Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Aspirin, Ibuprofen, Paracetamol and Others......29
Acne Drugs......30
Table 25: Acne Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Isotretinoin, Topicals (Retinoid/Antibiotics), Oral Antibiotics, and Others......30
Table 26: Anti-acne Topical Dermatology Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Acne, AK + Psoriasis + Dermatitis + Others, Anti-Fungal Combo, Anti-Infective, Coagulants, Corticosteroids Combo, and Corticosteroids Plain......31
Table 27: Acne Drugs Market by Segments in the US (2015) - Percentage Share Breakdown by Volume for Orals and Topicals......32
Cold, Cough Remedies......33
Table 28: Cough-Cold Medication Market by Product in the US (2015) - Percentage Share Breakdown by Value for Anticholinergics, Antihistamines, Benzonatate, Expectorants, Triple Combinations and Other......33
Table 29: Cough-Cold Medication (Narcotics & Non-Norcotics) Market by Product in the US (2015) - Percentage Share Breakdown by Value for Benzonatate, Codeine, Dextromethorphan and Hydrocodone......34
Table 30: Cough and Cold Treatments Market through Supermarkets, Drug Stores, and Mass Merchandisers, (Including Wal-Mart), Military Commissaries and Select Club and Dollar Retail Chains by Type in the US (2015) - Percentage Share Breakdown by Value for Chest Rubs, Cold, Allergy, and Sinus Liquids, Cold, Allergy, and Sinus Tablets, Cough Drops, Cough Syrup, and Nasal Products......35
Table 31: Cold-Allergy-Sinus (Liquid and Powder) Market through Supermarkets, Drug Stores, Mass Merchandisers (Including Wal-Mart) in the US (2015) in US$ Million......36
Table 32: Cold-Allergy-Sinus Treatments (Liquid) Market through Supermarkets, Drug Stores, Mass Merchandisers (Including Wal-Mart), Military Commissaries and Select Club and Dollar Stores in the US (2015) in US$ Million......37
Table 33: Cold-Allergy-Sinus Treatments (Tablets and Packets) Market through Supermarkets, Drug Stores, Mass Merchandisers (Including Wal-Mart), Military Commissaries and Select Club and Dollar Stores in the US (2015) in US$ Million......38
Dermatological Drugs......39
Table 34: Dermatological Drug Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Acne, Alopecia, Atopic Dermatitis, Herpes, Psoriasis, Rosacea, Skin Cancer, and Skin Infections......39
Table 35: Dermatology Drugs Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for France, Germany, Italy, Japan, Spain, UK, US, and Rest of World......40
Table 36: Dermatology Market by Category in the US (2015) - Percentage Share Breakdown by Value for Genericised, Off-Patent but No Generics, On-Patent, and Others......41
Table 37: Dermal Substitutes Chronic Wound Market by Category in the US (2015) - Percentage Share Breakdown by Value for Diabetic Foot Ulcer, Pressure Ulcer and Venous Leg Ulcer......42
Table 38: Prevalence & Severity of Actinic Keratoses Market by Category in the US (2015) - Percentage Share Breakdown by Value for Minimal, Moderate, Severe, and Others......43
Diabetes......44
Table 39: Diabetes Market by Region Worldwide (2015) - Percentage Share Breakdown for Africa, Europe, Middle East & North Africa, North America & Caribbean, Southeast Asia, and Western Pacific......44
Table 40: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type‐1 Diabetes, Insulin Type‐2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP‐1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others* (includes Sodium-Glucose Co-Transporter-2 (SGLT2), Biguanide, Sulfonylurea, Alpha-Glucosidase Inhibitors, Peroxisome Proliferator-Activated Receptor (PPAR)......45
Table 41: Diabetes Care Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Human Insulins, Modern Insulins, Victoza, and Others......46
Table 42: Type-II Diabetes Treatments Market Worldwide (2015-2020) in US$ Million......47
Table 43: Type II Diabetes Market by Treatment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-IV Inhibitors, GLP-1 Agonists, SGLT-2 Inhibitors and Thiazolidinediones......48
Table 44: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......49
Table 45: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......50
Table 46: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......51
Table 47: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......52
Table 48: No. of Diabetes Patients by Medication in the US (2015) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......53
Diabetes Drugs......54
Table 49: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......54
Table 50: Diabetes/Metabolic Drugs Market by Category Worldwide (2015) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......55
Table 51: Anti-Diabetic Drug Market by Treatment Class Worldwide (2015) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......56
Table 52: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......57
Table 53: Anti-Diabetic Drugs Market in China (2015-2020) in RMB Million......58
Table 54: Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glinide, Insulin, Sulfonylureas, α-glucosidase Inhibitor, and Others......59
Table 55: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......60
Table 56: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......61
Table 57: Diabetic Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for DPP-IV & SGLT-2, GLP-1, Insulins, and Others......62
Table 58: Diabetic Drugs Market by Non-Insulin Therapy in the US (2015) - Percentage Share Breakdown by Volume for Biguanides, DPP-4 Inhibitor, Human GLP-1 Analogs, SGLT-2 Inhibitor, Sulfonylureas, and Others......63
Table 59: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......64
Non-Insulin Anti-Diabetic Drugs......65
Table 60: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......65
Insulin......66
Table 61: Insulin Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Aspart (Novolog), Detemir (Levemir), Glargine (Lantus), Glulisine (Apidra), Lispro (Humalog), and Rh Insulin......66
Table 62: Insulin Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Basal Insulins, Prandial Insulins and Pre-Mixed Insulin......67
Table 63: Insulin Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Fast Acting, Long Acting and Premix......68
Table 64: Insulin Market by Generation in China (2015) - Percentage Share Breakdown by Value for 1st Generation, 2nd Generation, and 3rd Generation......69
Table 65: Insulin Market by Product Type in the US (2015) - Percentage Share Breakdown by Value for Fast-Acting, Human, Long-Acting and Mix......70
Antihypertensive Drugs......71
Table 66: Antihypertensive Drugs Market by Product in China (2105) - Percentage Share Breakdown by Value for Angiotensin II Receptor Blockers (ARBs), Beta Blocker, Calcium Channel Blocker and Others......71
Table 67: Hypertension Treatment Market by Segment in China (2015) - Percentage Share Breakdown by Value for Products to Regulate Blood Lipid Levels, and Products to Regulate Blood Sugar......72
Biologics......73
Table 68: Biologics Market by Component Worldwide (2015) - Percentage Share Breakdown by Value for Insulin, Multiple Sclerosis, Oncology, Tumor Necrosis Factor, and Others......73
Table 69: No. of Biologics in Development by Therapeutic Area Worldwide (2015) - Percentage Market Share Breakdown for Autoimmune Disorders, Blood Disorders, Cancer/ Related Conditions, Cardiovascular Disease, Diabetes/Related Conditions, Digestive Disorders, Eye Conditions, Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Neurologic Disorders, Respiratory Disorders, Skin Diseases, Transplantation, and Others......74
Table 70: Biological Drugs Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Daratumuma, Elotuzumab, MOR202 and SAR650984......75
Table 71: Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics, and Chemicals......76
Table 72: Therapeutic Biologics Market by Type in China (2015) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others......77
Table 73: Biologics Therapeutic Classes Market by Category in China (2015) - Percentage Share Breakdown by Value for Cardiovascular, CNS, Dermatology, Hematology, Metabolic, Musculoskeletal, Oncology, Urinary, and Others......78
Table 74: Dermatology Biologics Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and STELARA......79
Epilepsy Drugs......80
Table 75: Epilepsy Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Carbamazepine Generics, Depakote/ER Franchise (ABT), Depakote/ER Generics, Dilant in (PFE), Gabapent in Generics, Keppra Generics, Keppra/XR (UCB), Lamictal/XR (GSK), Lyrica (PFE), Trileptal (NVS), Vimpat (UCB), and Others......80
Gastrointestinal Drugs......81
Table 76: Gastrointestinal Market Worldwide (2015) in US$ Million......81
Table 77: Gastrointestinal Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for H2 Blockers, Proton Pump Inhibitors, and Others......82
Growth Hormones......83
Table 78: Growth Hormone Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, Japan and United States......83
Table 79: Growth Hormone Market by Growth Disorder Indication in Europe (2015) - Percentage Share Breakdown by Value for Adult Growth Hormone Deficiency (GHD), Pediatric Growth Hormone Deficiency (GHD), Turner Syndrome and Other......84
Table 80: Growth Hormone Market by Growth Disorder Indication in Japan (2015) - Percentage Share Breakdown by Value for Pediatric Growth Hormone Deficiency (GHD) and Turner Syndrome......85
Table 81: Growth Hormone Market by Growth Disorder Indication in the US (2015) - Percentage Share Breakdown by Value for Adult Growth Hormone Deficiency (GHD), Idiopathic Short Stature (ISS), Pediatric Growth Hormone Deficiency (GHD), Turner Syndrome and Others......86
Human Growth Hormones (hGH)......87
Table 82: Human Growth Hormone (hGH) Market by Growth Disorder Indication Worldwide (2015) - Percentage Share Breakdown by Value for Idiopathic Short Stature, Pediatric Growth Disorder Deficiency (GHD), Turner Syndrome and Others......87
Table 83: Human Growth Hormone Sales by Product in the US (2015) - Percentage Share Breakdown by Value for Genotropin (Pfizer), Humatrope (Eli Lilly), Norditropin (Novo Nordisk), Nutropin (Roche), Saizen, serostim (Merck KGaA) and Others......88
Cancer Drugs......89
Table 84: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......89
Table 85: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......90
Cancer Market......91
Table 86: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others*......91
Table 87: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......92
Table 88: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......93
Table 89: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......94
Table 90: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......95
Table 91: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......96
Table 92: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......97
Table 93: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......98
Cancer Patients......99
Table 94: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......99
Table 95: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......100
Table 96: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......101
Table 97: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......102
Table 98: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......103
Table 99: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......104
Table 100: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......105
Table 101: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......106
Table 102: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......107
Table 103: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......108
Table 104: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......109
Table 105: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......110
Table 106: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......111
Table 107: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......112
Table 108: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......113
Table 109: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix Uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......114
Table 110: No. of Bladder Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......115
Table 111: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......116
Table 112: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......117
Table 113: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......118
Table 114: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......119
Cervical Cancer......120
Table 115: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......120
Table 116: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......121
Hematological Cancer......122
Table 117: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......122
Skin Cancer......123
Table 118: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......123
Cancer-Associated Mucositis......124
Table 119: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......124
Chronic Myelogenous Leukemia (CML)......125
Table 120: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......125
Multiple Myeloma......126
Table 121: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......126
Table 122: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......127
Ophthalmic Drugs......128
Table 123: Ophthalmic Antibiotic Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Besivance, Moxeza, Vigamox, Zymaxid and Generic & Others......128
Table 124: Ophthalmic Steroid Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Alrex, Durezol, Lotemax, Ozurdex and Generic & Others......129
Pharmaceutical Benefits Scheme (PBS) Prescription......130
Table 125: Pharmaceutical Benefits Scheme (PBS) Prescription Market by Company in Australia (2014) - Percentage Market Share Breakdown by Volume Sales for Alphapharm, AstraZeneca Plc, Eli Lilly and Company, GlaxoSmithKline Plc, Janssen Pharmaceuticals, Merck & Co., Inc., Novartis, Pfizer, Inc., Sanofi S.A., Wyeth, and Others......130
Pain Management Drugs......131
Table 126: Market Shares of Leading Pain Management Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Endo International Plc, Johnson & Johnson, Pfizer, Inc., and Others......131
Table 127: Market Shares of Leading Pain Remedies Manufacturers for Over-the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for Bayer HealthCare AG, Johnson & Johnson Private Limited, Pfizer, Inc., Prestige Brands Holdings, Inc., Private-label and Others......132
Table 128: Market Shares of Leading Pain Remedy Producers Sales in the US OTC Market (2014) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., Prestige Brands Holdings, Inc., Private Label and Others......133
Table 129: Market Shares of Leading Oral Pain Relief Brands through Food Store in the US (2015) - Percentage Share Breakdown by Value for Anbesol, Baby Orajel, Kank A, Kank A Softbrush, Orajel, Private Label, and Others......134
Table 130: Market Shares of Leading Oral Pain Relief Brands through Supermarkets, Drugstores, Mass Merchandisers (including Wal-Mart), Gas & Convenience Stores, Military Commissaries, and Select Club and Dollar Retail Chains in the US (2015) - Percentage Share Breakdown by Value for Anbesol, BabyOrajel, Hyland's, KankA, Orajel, and Other......135
Table 131: Market Shares of Leading Oral Pain Remedy Brands by Value Sales through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Share Breakdown for Anbesol, Baby Orajel, Glyoxide, Kank-A, Orajel, Private Label, and Others......136
Central Nervous System (CNS) Medicines......137
Table 132: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......137
Table 133: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......138
Women's Health Therapeutics......139
Table 134: Market Shares of Leading Women's Health Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Merck Ltd., Novo Nordisk A/S, Pfizer, Inc., and Others......139
Vaccines......140
Table 135: Market Shares of Leading Vaccine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc (GSK), Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......140
Diphtheria and Tetanus Vaccines......141
Table 136: Market Shares of Leading Diphtheria and Tetanus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Infanrix), and Others......141
Hepatitis A Vaccines......142
Table 137: Market Shares of Leading Hepatitis A Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Havrix), and Others......142
Hepatitis B (Recombinant) Vaccines......143
Table 138: Market Shares of Leading Hepatitis B (Recombinant) Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Engerix (GlaxoSmithKline Plc), and Others......143
Hepatitis A and Typhoid Polysaccharide Vaccines......144
Table 139: Market Shares of Leading Hepatitis A and Typhoid Polysaccharide Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Hepatyrix), and Others......144
Human Papillomavirus Vaccines......145
Table 140: Market Shares of Leading Human Papillomavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Cervarix), and Others......145
Human Rotavirus Vaccines......146
Table 141: Market Shares of Leading Human Rotavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Rotarix), and Others......146
Influenza Vaccines......147
Table 142: Market Shares of Leading Influenza Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Fluarix), and Others......147
Measles, Mumps and Rubella Vaccines......148
Table 143: Market Shares of Leading Measles, Mumps and Rubella Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Priorix), and Others......148
Tetanus Toxoid, reduced Diphthera Vaccines......149
Table 144: Market Shares of Leading Tetanus Toxoid, reduced Diphthera Vaccine Manufacturers in India (2014) - Percentage Breakdown by Value Sales for GlaxoSmithKline Plc (Boostrix), and Others......149
Typhoid Vaccines......150
Table 145: Market Shares of Leading Typhoid Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Typherix), and Others......150
Varilrix Vaccines......151
Table 146: Market Shares of Leading Varilrix Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Varilrix), and Others......151
Respiratory Therapeutics......152
Table 147: Market Shares of Leading Respiratory Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......152
Anti-Infectives......153
Table 148: Market Shares of Leading Anti-Infective Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Bayer AG, Merck & Co., Inc., Vétoquinol S.A., Virbac S.A., Zoetis, Inc. and Other......153
Cardiology Therapeutics......154
Table 149: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......154
Antibiotics......155
Table 150: Branded Acute Bacterial Skin and Skin Structure Infection Antibiotic Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Cubicin (Daptomycin), Teflaro (Ceftaroline), Tygacil (Tigecycline), and Zyvox (Linezolid)......155
Table 151: Branded Community-Acquired Bacterial Pneumonia Antibiotic Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Teflaro (Ceftaroline), Tygacil (Tigecycline), and Zyvox (Linezolid)......156
Erectile Dysfunction Drugs......157
Table 152: Market Shares of Leading Erectile Dysfunction Drugs Brands in the US (2015) - Percentage Breakdown by Value for Cialis, Viagra, and Others......157
Table 153: Market Shares of Leading Erectile Dysfunction (ED) Drug Brands by Value Sales in Korea (2014) - Percentage Breakdown for Cialis, Levitra, Mvix, Viagra, Yaila, and Zydena......158
Allergy Care Products......159
Table 154: Market Shares of Leading Allergy Immunotherapy Treatment Providers Worldwide (2015) - Percentage Breakdown by Value for ALK-Abelló, Greer Laboratories, Inc., and Others......159
Table 155: Market Shares of Leading Allergy Immunotherapy Treatment Providers in the UK (2015) - Percentage Breakdown by Value for ALK, Allergopharma, Allergy Therapeutics, HAL Allergy, Leti/Novartis, Stallergenes, and Others......160
Table 156: Market Shares of Leading Allergy Care Product Companies by Value Sales in the US (2014) - Percentage Breakdown for Johnson & Johnson Inc., Merck & Co Inc., Novartis AG, Pfizer Inc., Prestige Brands Holdings Inc., Sanofi S A, Private Label and Others......161
Table 157: Allergy Drug Market in the UK (2015) - Percentage Share Breakdown by Value for Allegra, Allelock, Clarinex, Claritin, Zyrtec, and Others......162
Amlodipine Besylate Tablets......163
Table 158: Market Shares of Leading Amlodipine Besylate Tablet Manufacturers for Antihypertensive Therapy Worldwide (2015) - Percentage Share Breakdown by Hospital Sales for Pfizer, Inc., Saike Pharmaceutical Co., Ltd., Yangtze River Pharmaceutical Group, and Others......163
Analgesic (Internal Tablet)......164
Table 159: Market Shares of Leading Analgesic (Internal Tablet) Manufacturers by Value Sales at Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Breakdown for Bayer Consumer Health Division, McNeil Consumer Products, Pfizer, Inc., Private Label, and Others......164
Table 160: Market Shares of Leading Analgesics Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Pfizer, Inc., Reckitt Benckiser Plc, and Others......165
Table 161: Market Shares of Leading Anaesthetics & Analgesics Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......166
Table 162: Market Shares of Leading Analgesics Manufacturers in Africa Middle East (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Reckitt Benckiser Group and Others......167
Table 163: Market Shares of Leading Analgesics Manufacturers in Asia-Pacific (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Reckitt Benckiser Group and Others......168
Table 164: Market Shares of Leading Analgesics Manufacturers in Europe (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Reckitt Benckiser Group and Others......169
Table 165: Market Shares of Leading Analgesic Product Manufacturers in India (2015) - Percentage Share Breakdown by Value for Emami Ltd., Glaxo SmithKline Consumer Healthcare Ltd., Reckitt Benckiser Group Plc, and Others......170
Table 166: Market Shares of Leading Analgesic Products Brands in India (2015) - Percentage Share Breakdown by Value for Zandu Balm & Mentha Balm, and Others......171
Table 167: Market Shares of Leading Analgesics Brands in Indonesia (2015) - Percentage Share Breakdown by Value for Bodrex (regular), Oskadon, Paramex, Puyer 16 and Others......172
Table 168: Market Shares of Leading Analgesics Brands in Indonesia (2015) - Percentage Share Breakdown by Volume for Bodrex (regular), Oskadon, Paramex, Puyer 16 and Others......173
Table 169: Market Shares of Leading Analgesics Manufacturers in Latin America (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson and Others......174
Table 170: Market Shares of Leading Analgesic Brands in Nigeria (2015) - Percentage Breakdown by Value for Alabukun, Emzor, Pandol, and Others......175
Table 171: Market Shares of Leading Analgesics Manufacturers in North America (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson and Others......176
Acne Drugs......177
Table 172: Market Shares of Leading Branded Anti-Acne Drug Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Allergan, Inc., Galderma, Valeant Pharmaceuticals International, Inc. and Others......177
Table 173: Market Shares of Leading Branded Anti-acne Treatement Providers Worldwide (2015) - Percentage Share Breakdown by Value for Allergan, plc, Bayer AG, Galderma S.A., GlaxoSmithKline Pharmaceuticals Ltd., Prasco Laboratories, Valeant Pharmaceuticals International, Inc., and Others......178
Table 174: Market Shares of Leading Generic Anti-Acne Drug Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Mylan, Perrigo Company, Pfizer, Inc., Sandoz and Others......179
Table 175: Market Shares of Leading Generic Anti-acne Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Mylan N.V., Perrigo Company plc, Pfizer, Inc., Prasco Laboratories, Rouses Point Pharmaceuticals LLC, Sandoz Inc., Taro Pharmaceutical Industries Ltd., and Private Label......180
Table 176: Topical Prescription Acne Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Volume for Cash Payment, Commercial, and Managed Medicaid Payment, Medicare Payment......181
Table 177: Market Shares of Leading Topical Acne Treatment Brands in the US (2015) - Percentage Market Share Breakdown by Volume for Acanya, Aczone, Differin, Epiduo, Finacea, and Others......182
Table 178: Oral Prescription Acne Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Volume for Cash Payment, Commercial, and Medicare Payment......183
Table 179: Market Shares of Leading Oral Acne Treatment Brands in the US (2015) - Percentage Market Share Breakdown by Volume for Doryx, Monodox, Oracea, Solodyn, and Others......184
Atorvastatin Calcium Tablets (A LE)......185
Table 180: Market Shares of Leading Atorvastatin Calcium Tablets (A LE) Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Beijing Jialin Pharmaceutical Co, Ltd., Pfizer, Inc. and Others......185
Calming and Sleeping Product......186
Table 181: Market Shares of Leading Calming and Sleeping Product Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Pfizer, Inc., Procter & Gamble Co., and Others......186
Clinical Nutritional Products......187
Table 182: Market Shares of Leading Clinical Nutritional Products Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Abbott Nutriton, Inc., Dannon Group, Mead Johnson Nutrition Company, Nestlé S.A., Pfizer, Inc., and Others......187
Consumer Health Products......188
Table 183: Market Shares of Leading Healthcare Products Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Ecolab, Inc. and Others......188
Table 184: Market Shares of Leading Consumer Health Products Manufacturers in Indonesia (2015) - Percentage Share Breakdown by Value for Kalbe Farma Tbk PT, SOHO Group, Tempo Scan Pacific Tbk PT and Others......189
Table 185: Market Shares of Leading Consumer Health Product Producers by Value Sales in the US (2014) - Percentage Breakdown for Bayer AG, General Nutrition Centres, Inc., Glanbia Plc, GlaxoSmithKline Plc, Herbalife Ltd., Johnson & Johnson, Inc., Living Essentials, LLC, Merck & Co, Inc., NBTY, Inc., Novartis AG, Otsuka Holdings Co., Ltd., Pfizer, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Reckitt Benckiser Plc, Sanofi SA, Private Label, and Others......190
Table 186: Market Shares of Leading Consumer Health Product Producers by Value Sales in the US OTC Market (2014) - Percentage Breakdown for Bayer AG, GlaxoSmithKline Plc., Johnson & Johnson Inc., Merck & Co Inc., Novartis AG, Pfizer Inc., Prestige Brands Holdings Inc., Procter & Gamble Co., Reckitt Benckiser Plc., Sanofi S.A., Private Label and Others......191
Table 187: Market Shares of Leading Consumer Health Product Manufacturers in US (2015) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson Inc, Living Essentials, Merck & Co., Inc., NBTY, Inc., Novartis AG, Pfizer Inc, Procter & Gamble Co., Private-Label and Others......192
Cold, Cough Remedies......193
Table 188: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC Worldwide (2015) - Percentage Share Breakdown by Value for Johnson & Johnson, Procter & Gamble Co., and Others......193
Table 189: Market Shares of Leading Manufacturers for Cough and Cold Remedies Worldwide (2015) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson, Pfizer, Inc., Procter & Gamble Co., Reckitt Benckiser Group Plc, Sanofi S.A., Private Label and Others......194
Table 190: Market Shares of Leading Cough, Cold Allergy Medicine Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Johnson & Johnson, Pfizer, Inc., Procter & Gamble Co., Reckitt Benckiser Plc, and Others......195
Table 191: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC in Africa Middle East (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson and Others......196
Table 192: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC in Asia-Pacific (2015) - Percentage Share Breakdown by Value for Johnson & Johnson, Procter & Gamble Co., and Others......197
Table 193: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC in Europe (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Procter & Gamble Co., and Others......198
Table 194: Market Shares of Leading Cold Remedies Brands in Indonesia (2015) - Percentage Share Breakdown by Value for Bodrex Flu Batuk, Decolgen, Mixagrip, Pro Cold, Ultra Flu and Others......199
Table 195: Market Shares of Leading Cold Remedies Brands in Indonesia (2015) - Percentage Share Breakdown by Volume for Bodrex Flu Batuk, Decolgen, Mixagrip, Pro Cold, Ultra Flu and Others......200
Table 196: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC in Latin America (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Procter & Gamble Co., and Others......201
Table 197: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC in North America (2015) - Percentage Share Breakdown by Value for Johnson & Johnson, Procter & Gamble Co., and Others......202
Table 198: Market Shares of Leading Cough & Cold Medicine Manufacturers by Value Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......203
Table 199: Market Shares of Leading Cough & Cold Medicine Manufacturers by Volume Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......204
Table 200: Market Shares of Leading Cold, Allergy and Sinus (Liquid and Powder) Brands through Supermarkets, Drug Stores, and Mass Merchandisers, Military Commissaries and Select Club and Dollar Retail Chains in the US (2015) - Percentage Breakdown by Value for Children's Benadryl, Children's Dimetapp, Children's Mucinex, Mucinex Fast Max, Nasacort, Tylenol Cold, Vicks Dayquil, Vicks Nyquil, Vicks Nyquil and Dayquil, Private Label, and Others......205
Table 201: Market Shares of Leading Cold, Allergy and Sinus (Liquid) Brands through Supermarkets, Drug Stores, and Mass Merchandisers, (Including Wal-Mart), Military Commissaries and Select Club and Dollar Stores in the US (2015) - Percentage Breakdown by Value for Benadryl, Dimetapp, Mucinex, Mucinex Fast Max, Robitussin, Tylenol Cold, Tylenol Cold, Vicks Dayquil, Vicks Nyquil, Vicks Nyquil and Vicks Dayquil, Private Label, and Others......206
Table 202: Market Shares of Leading Cold, Allergy and Sinus Remedy (Tablet and Packet) Brands through Supermarkets, Drug Stores, and Mass Merchandisers, Military Commissaries and Select Club and Dollar Retail Chains in the US (2015) - Percentage Breakdown by Value for Alka Seltzer Plus, Allegra, Allegra D, Benadryl, Claritin, Claritin D, Mucinex, Mucinex DM, Zyrtec, Private Label, and Others......207
Table 203: Market Shares of Leading Cold, Allergy and Sinus Remedy (Tablet, Packet) Manufacturers by Value Sales through Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Breakdown for Chattem Chemicals, Inc., McNeil Consumer Healthcare, Merck & Co., Inc., RB plc, Private Label, and Others......208
Table 204: Market Shares of Leading Cough Drop Manufacturers through Supermarkets, Drug Stores, Mass Merchandisers (Including Wal-Mart), Gas and Convenience Stores, Military Commissaries and Select Dollar and Club Chains in the US (2015) - Percentage Breakdown by Value for Mondelez International, Prestige Brands Holdings, Inc. (Luden's), Reckitt Benckser, Inc. (Cepacol), Ricola, Inc., Private Label, and Others......209
Table 205: Market Shares of Leading Cough Syrup Manufacturers through Drug Store in the US (2015) - Percentage Breakdown by Value for Novartis AG, Pfizer, Inc., Procter & Gamble Co., ReckittBenckiser, Inc., and Others......210
Table 206: Market Shares of Leading Cough Syrup Manufacturers through Food Stores in the US (2015) - Percentage Breakdown by Value for Honey Naturals LLC, Pfizer, Inc., Prestige Brands Holdings, Inc., Procter and Gamble Co., Reckitt Benckiser, Inc., Private Label, and Others......211
Table 207: Market Shares of Leading Cough and Sore Throat Drop Manufacturers through Drug Stores in the US (2015) - Percentage Breakdown by Value for Kraft Heinz Company, Prestige Brands Holdings, Inc., Reckitt Benckiser, Inc., Ricola, Inc., Private Label, and Others......212
Table 208: Market Shares of Leading Cough and Cold Remedies Manufacturers for Over-the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for Johnson & Johnson Private Limited, Merck & Co., Inc., Prestige Brands Holdings, Inc., Reckitt Benckiser Group Plc., Sanofi S.A., Private-Label and Others......213
Table 209: Market Shares of Leading Cough/Cold Remedy Producers by Value Sales in the US OTC Market (2014) - Percentage Breakdown for Johnson & Johnson, Merck & Co., Inc., Prestige Brands Holdings, Inc., Reckitt Benckiser plc., Sanofi S.A. Private Label, and Others......214
Dermatological Products......215
Table 210: Market Shares of Leading Dermatological Product Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Pfizer, Inc., Reckitt Benckiser Plc, and Others......215
Table 211: Market Shares of Leading Dermatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Biogen Idec, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, and Others......216
Table 212: Market Shares of Leading Therapeutic Dermatology (excluding Aesthetics) Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Inc. (ABBV), Galderma S.A., GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Pfizer, Inc. (PFE), Amgen, Inc. (AMGN), Valeant Pharmaceuticals Intl, Inc., Dermik Laboratories, and Others......217
Table 213: Market Shares of Leading Drugs for Treatment of Skin Infection in the US (2015) - Percentage Share Breakdown by Value for CUBICIN, VANCOMYCIN, ZYVOX IV and Others......218
Diabetes Drugs......219
Table 214: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......219
Table 215: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......220
Table 216: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......221
Antihypertensive Drugs......222
Table 217: Market Shares of Leading Antihypertensive Drugs Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for AstraZeneca, Bayer AG, Novartis International AG, Pfizer, Inc., Sanofi-Aventis and Others......222
Biologics......223
Table 218: Market Shares of Leading Biologics/Vaccines Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Boehringer Ingelheim GmbH, Ceva, Merck & Co., Inc., Merial, Zoetis, Inc. and Others......223
Table 219: Market Shares of Leading Anti-Inflammatory Biologic Brands Worldwide (2015) - Percentage Share Breakdown by Value for Actemra, Enbrel, Humira, Remicade and Others......224
Table 220: Market Shares of Leading Biologic Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Value for AbbVie Inc., Amgen, Inc. and Pfizer, Inc., Johnson & Johnson, Roche Holding AG and Others......225
Female Hormone Drugs......226
Table 221: Market Shares of Leading Female Hormone Drugs Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Naturalendo, Novo Nordisk, Pfizer, Inc., Warner Chilcott and Others......226
Injectable Drugs......227
Table 222: Market Shares of Leading Injectable Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co. KGaA, Hospira, Inc., Novartis AG, Pfizer, Inc., West-Ward Pharmaceuticals Corporation, and Others......227
Table 223: Market Shares of Leading Generic Injectable Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Fresenius SE & Co., Hikma Pharmaceuticals, Hospira, Inc., Luitpold Pharmaceuticals, Inc. and Others......228
Table 224: Market Shares of Leading Injectable Manufacturers by Value Sales in France (2014) - Percentage Breakdown for Aguettant Limited, Baxter International, Inc., B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., Lake Forest Park Medical Clinic (LFP), Mylan Laboratories, Inc., Novartis International AG (Sandoz), Laboratoires PANPHARMA S.A., Sanofi S.A., and Others......229
Table 225: Market Shares of Leading Injectable Manufacturers by Value Sales in Germany (2014) - Percentage Breakdown for AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Medac GmbH, Novartis International AG (Sandoz), Sanofi S.A.,Teva Pharmaceutical Industries Ltd. and Others......230
Table 226: Market Shares of Leading Injectable Manufacturers by Value Sales in Italy (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Hospira, Inc., Johnson & Johnson, KEDRION GROUP S.p.A., Novartis International AG (Sandoz), Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd. and Others......231
Table 227: Market Shares of Leading Injectable Manufacturers by Value Sales in Spain (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Ges Genericos Españoles Laboratorio S.A., Grifols, S.A, Hospira, Inc., Johnson & Johnson, Normon S.A., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......232
Table 228: Market Shares of Leading Injectable Manufacturers by Value Sales in the UK (2014) - Percentage Breakdown for Actavis Plc (Watson), AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Hospira, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......233
Table 229: Market Shares of Leading Injectable Miotics Manufacturers in the US (2015) - Percentage Breakdown by Value for Alcon Incorporated, and Novartis International AG......234
Pharmaceuticals......235
Table 230: Market Shares of Leading Pharmaceutical Companies in Australia (2015) - Percentage Share Breakdown by Value for AstraZeneca, Pfizer, Inc. and Others......235
Table 231: Market Shares of Leading Pharmaceutical Distributors in Brazil (2015) - Percentage Share Breakdown by Value for Panpharma Participacoes S.A., Profarma Distribuidora de Produtos Farmaceuticos S.A., Santa Cruz and Other......236
Table 232: Market Shares of Leading Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma Tbk., Pfizer Indonesia PT Tbk, Sanbe Farma PT, and Others......237
Table 233: Market Shares of Leading Pharmaceutical Suppliers to Hospitals in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma, Tbk, Sanbe Farma PT, Soho Group, and Others......238
Table 234: Market Shares of Leading Pharmaceutical Drugs Manufacturers in the US (2015) - Percentage Breakdown by Value for Amgen, Eli Lilly and Co., Johnson and Johnson Co, Merck & Co., Inc., Pfizer, Inc., and Others......239
Table 235: Market Shares of Leading Pharmaceutical Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Abbott Laboratories, Amgen Corporation, AstraZeneca Plc, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......240
Prescription Pharmaceuticals......241
Table 236: Market Shares of Leading Prescription Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Volume Sales for Dexa Medica Group, Interbat Pharmaceutical Industry PT, PT Kalbe Farma, Tbk, PT Sanbe Farma, and Others......241
Table 237: Market Shares of Leading RX Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Eurofarma Laboratórios, Hypermarcas S.A.,Pfizer, Inc., Roche AG, Sanofi - Medley Indústria Farmacêutica Ltda and Others......242
Table 238: Market Shares of Leading Prescription Pharmaceutical Companies in the US (2014) - Percentage Market Share Breakdown by Volume Sales for Actavis Plc, Amneal, Inc., Endo Pharma, Inc., Lupin Pharmaceuticals, Inc., Mylan Labs,Inc., Novartis International AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and Others......243
Table 239: Market Shares of Leading Prescription Drug Companies in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries, Ltd., and Others......244
Table 240: Market Shares of Leading Prescription Drug Companies Spending through Media Ads in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......245
Epilepsy Therapeutics......246
Table 241: Market Shares of Leading Epilepsy Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......246
Baby Food......247
Table 242: Market Shares of Leading Baby Food Manufacturers in Latin America in 2014: Percentage Shares in Sales Value held by Mead Johnson & Company, Nestle SA, and Pfizer, Inc.......247
Table 243: Market Shares of Leading Baby Food Manufacturers in Saudi Arabia in 2014: Percentage Shares in Sales Value held by Abbott Nutrition, Groupe Danone, HiPP UK Ltd., Nestle SA, and Pfizer, Inc.......248
Gastrointestinal Drugs......249
Table 244: Market Shares of Leading Gastrointestinal, Ulcer Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Pfizer, Inc., and Others......249
Table 245: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......250
Table 246: Market Shares of Leading Gastrointestinal (GI) Remedies Manufacturers for Over- the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for GlaxoSmithKline Pharmaceuticals Limited, Johnson & Johnson Private Limited, Novartis Consumer Health, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Private Label and Others......251
Table 247: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......252
Table 248: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Volume Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......253
Pediatrics Formula......254
Table 249: Market Shares of Leading Pediatrics Formula Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Abbott Laboratories, Danone S.A, Hangzhou Beingmate Group Co., Ltd., Mead Johnson Nutrition Company, Nestle S.A., Pfizer, Inc., and Others......254
Glargine......255
Table 250: Market Shares of Leading Glargine Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Pfizer India Limited, Sanofi India Limited and Wockhardt Ltd.......255
Hemophilia Medicine......256
Table 251: Market Shares of Leading Hemophilia Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Baxter International, Inc., Bayer AG, CSL Limited, Grifols, S.A., Kedrion S.p.A, Novo Nordisk A/S, Octapharma AG, and Pfizer, Inc.......256
Haemophilia A......257
Table 252: Market Shares of Leading Haemophilia A Treatment Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value Sales for Baxter International Inc. (Advate), Bayer AG (Kogenate), CSL Behring, LLC (Helixate), Pfizer, Inc. (Refacto) and Others......257
Haemophilia B......258
Table 253: Market Shares of Leading Haemophilia B Treatment Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value Sales for Pfizer, Inc. (Benefix) and Others......258
Table 254: Market Shares of Leading Haemophilus B Conjugate Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Hiberix), and Others......259
Hemophilia Treatment......260
Table 255: Market Shares of Leading Hemophilia Treatment Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Baxter International, Inc., Bayer AG, CSL Ltd. Novo Nordisk, Pfizer, Inc., and Others......260
Herbal Products......261
Table 256: Market Shares of Leading Herbal Products Producers by Value Sales in the US (2014) - Percentage Breakdown for General Nutrition Centres, Inc., GlaxoSmithKline Plc, Herbalife Ltd., Johnson & Johnson, Inc., NBTY, Inc., Novartis AG, Pfizer, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Sanofi SA, Private Label and Others......261
Growth Hormone......262
Table 257: Market Shares of Leading Growth Hormone Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Eli Lilly and Company (humatrope), Novo Nordisk (Norditropin), Pfizer, Inc. (Genotropin), Roche Holdings AG (Nutropin) and Others......262
Human Growth Hormones (HGH)......263
Table 258: Market Shares of Leading Human Growth Hormones (HGH) Producers Worldwide (2015) - Percentage Breakdown by Value for Eli Lilly and Company (Humatrope), Merck KGaA (Saizen,Serostim), Novo Nordisk A/S (Norditropin), Pfizer Inc. (Genotropin), Roche Holding AG (Nutropin), Teva Pharmaceutical Industries Ltd. (Tev-Tropin) and Others......263
Table 259: Market Shares of Leading Human Growth Hormones (HGH) Producers in the US (2015) - Percentage Breakdown by Value for Eli Lilly and Company, Genentech, Inc. and Roche Holding AG, Merck KGaA, Novartis International AG, Novo Nordisk A/S, Pfizer, Inc. and Teva Pharmaceutical Industries Ltd.......264
Infant Formula......265
Table 260: Market Shares of Leading Infant Formula Manufacturers Worldwide in 2014: Percentage Shares in Sales Value held by Abbott Nutrition, Groupe Danone, Mead Johnson & Company, Nestle SA, and Pfizer, Inc.......265
Table 261: Market Shares of Leading Infant Formula Manufacturers in Mexico in 2014: Percentage Shares in Sales Value held by Abbott Nutrition, Mead Johnson & Company, Nestle SA, and Pfizer, Inc.......266
Table 262: Market Shares of Leading Infant Formula Manufacturers in UK in 2014: Percentage Shares in Sales Value held by Groupe Danone, HiPP UK Ltd., Mead Johnson & Company, and Pfizer, Inc.......267
Table 263: Market Shares of Leading Infant Formula Manufacturers in China in 2014: Percentage Shares in Sales Value held by Groupe Danone, Hangzhou Beingmate Group, Mead Johnson & Company, Nestle SA, and Pfizer, Inc.......268
Table 264: Market Shares of Leading Infant Formula Manufacturers in Indonesia in 2014: Percentage Shares in Sales Value held by Abbott Nutrition, Groupe Danone, Mead Johnson & Company, Nestle SA, and Pfizer, Inc.......269
Table 265: Market Shares of Leading Infant Formula Manufacturers in Malaysia in 2014: Percentage Shares in Sales Value held by Abbott Nutrition, Groupe Danone, Mead Johnson & Company, Nestle SA, and Pfizer, Inc.......270
Table 266: Market Shares of Leading Infant Formula Manufacturers in Thailand in 2014: Percentage Shares in Sales Value held by Abbott Nutrition, Groupe Danone, Mead Johnson & Company, Nestle SA, and Pfizer, Inc.......271
Table 267: Market Shares of Leading Infant Formula Manufacturers in Taiwan in 2014: Percentage Shares in Sales Value held by Abbott Nutrition, Mead Johnson & Company, Nestle SA, and Pfizer, Inc.......272
Table 268: Market Shares of Leading Infant Formula Manufacturers in Australia in 2014: Percentage Shares in Sales Value held by Groupe Danone, H. J. Heinz Company, Nestle SA, and Pfizer, Inc.......273
Table 269: Market Shares of Leading Infant Formula Manufacturers in Chile in 2014: Percentage Shares in Sales Value held by Abbott Nutrition, Mead Johnson & Company, Nestle SA, and Pfizer, Inc.......274
Table 270: Market Shares of Leading Infant Formula Manufacturers in Colombia in 2014: Percentage Shares in Sales Value held by Abbott Nutrition, Groupe Danone, Mead Johnson & Company, Nestle SA, and Pfizer, Inc.......275
Table 271: Market Shares of Leading Infant Formula Manufacturers in South Africa in 2014: Percentage Shares in Sales Value held by Abbott Nutrition, Nestle SA, and Pfizer, Inc.......276
Table 272: Market Shares of Leading Infant Formula Manufacturers in Egypt in 2014: Percentage Shares in Sales Value held by Groupe Danone, Nestle SA, and Pfizer, Inc......277
Table 273: Market Shares of Leading Infant Formula Manufacturers in Philippines (2015) - Percentage Breakdown by Value for Abbott Laboratories, Mead Johnson Nutrition Company, Nestlé S.A, Pfizer Inc. and Others......278
Table 274: Market Shares of Leading Infant Formula Manufacturers in Saudi Arabia (2015) - Percentage Breakdown by Value for Abbott Laboratories, Danone Group S.A, Nestlé S.A, Pfizer and Others......279
Infant Milk Powder......280
Table 275: Market Shares of Leading Infant Milk Powder Manufacturers by Value Sales in China (2015) - Percentage Share Breakdown for Abbott Laboratories, Beingmate Baby & Child Food Co., Ltd., Groupe Danone, Mead Johnson & Co., LLC, Pfizer, Inc., Yili Com., Inc., and Others......280
Insulin......281
Table 276: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A., and Others......281
Table 277: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Volume Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A., and Others......282
Table 278: Market Shares of Leading Fast & Intermediate Type Insulin Producers Worldwide (2015) - Percentage Share Breakdown by Value for Eli Lilly and Company, Novo Nordisk, Sanofi S.A. and Others......283
Table 279: Market Shares of Leading Long-Acting Insulin Producing Companies Worldwide (2015) - Percentage Share Breakdown by Value for Sanofi S.A., Wockhardt Ltd., and Others......284
Table 280: Market Shares of Leading Insulin Companies in China (2014) - Percentage Share Breakdown by Value for Eli Lilly and Company, GanLee Pharmaceutical Co., Ltd., Novo Nordisk, Sanofi S.A., Shanghai Fosun Pharmaceutical Group Co., Ltd., United Laboratories International Holdings Ltd. (The), Tonghua Dongbao Pharmaceutical Co., Ltd., and Others......285
Table 281: Market Shares of Leading Insulin Companies in China (2015) - Percentage Share Breakdown by Volume for Novo Nordisk, Tonghua Dongbao Pharmaceutical Co., Ltd., Wanbang Biopharmaceuticals Co., Ltd. and Others......286
Table 282: Market Shares of Leading Insulin Companies in Europe (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......287
Table 283: Market Shares of Leading Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Ltd., Cadila Pharmaceuticals Ltd., Eli Lilly and Company India Pvt. Ltd., Lupin Pharmaceuticals, Inc., Novo Nordisk India Ltd., Pfizer India Ltd., Ranbaxy Laboratories Ltd., Sanofi India Ltd., Shreya Life Sciences Pvt. Ltd., USV Ltd., and Wockhardt Ltd.......288
Table 284: Market Shares of Leading Insulin Companies in Japan and Korea (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......289
Table 285: Market Shares of Leading Insulin Companies in North America (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......290
Installed Capacity of Biopharmaceutical Companies......291
Table 286: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S.A., and Others......291
Irinotecan......292
Table 287: Market Shares of Leading Irinotecan Manufacturers in the US (2015) - Percentage Breakdown by Value for APP Pharmaceuticals, Inc., Hospira, Inc., Novartis International AG, Pfizer, Inc. and Teva Pharmaceutical Industries Ltd.......292
Adult Mouth Product......293
Table 288: Market Shares of Leading Adult Mouth Product Manufacturers by Value Sales Worldwide (2014) - Percentage Share Breakdown for Johnson & Johnson, Reckitt Benckiser Plc, Pfizer, Inc., PL, and Others......293
MRSA Drugs......294
Table 289: MRSA Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value Sales for Cubicin, Semi-Synthetics/SYNERCID, Tygacil, Vancomycin, Zyvox IV, and Zyvox Oral......294
Multivitamins......295
Table 290: Market Shares of Leading Multivitamin Manufacturers by Value Sales through Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Share Breakdown for Bausch & Lomb, Inc., Bayer AG, Church & Dwight Co., Inc., Pfizer, Inc., Pharmative, LLC, Reckitt Benckiser Group plc, Private Label, and Others......295
Table 291: Market Shares of Leading Multivitamin Manufacturers through Supermarkets, Drug Stores, and Mass Merchandisers in the US (2015) - Percentage Breakdown by Value for Airborne (Reckitt Benckiser Group plc), Bausch & Lomb Inc., Bayer AG, Church & Dwight Co., Inc., Nature's Way Products, LLC, Pfizer, Inc., Private Label, and Others......296
Cancer Drugs......297
Table 292: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......297
Table 293: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......298
Table 294: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......299
Table 295: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......300
Table 296: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......301
Breast Cancer Drugs......302
Table 297: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......302
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......303
Table 298: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......303
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......304
Table 299: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Other......304
Table 300: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Others......305
Paediatric Nutritional......306
Table 301: Market Shares of Leading Paediatric Nutritional Companies by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Groupe Danone, Mead Johnson & Co., Nestlé S.A, Pfizer Inc. and Others......306
Ophthalmology Drugs......307
Table 302: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......307
Table 303: Market Shares of Leading Ophthalmic Steroids Brands in the US (2015) - Percentage Share Breakdown by Value for Fluorometholone, Lotemax, Prednisolone and Others......308
Orphan Disease Therapeutics......309
Table 304: Market Shares of Leading Orphan Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Pfizer, Inc., Sanofi S.A., and Others......309
Over-The-Counter (OTC)......310
Table 305: Market Shares of Leading Over-the-Counter (OTC) Product Manufacturers in US (2015) - Percentage Breakdown by Value for Bayer AG, GlaxoSmithKline Plc, Johnson & Johnson Inc, Merck & Co., Inc., Novartis AG, Pfizer Inc, Prestige Brands Holdings Inc, Procter & Gamble Co., Reckitt Benckiser Plc, Sanofi S.A., Private-Label and Others......310
Pediatric Health Product......311
Table 306: Market Shares of Leading Pediatric Health Product Manufacturers in the US (2015) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson Inc, Merck & Co., Inc., Novartis AG, Pfizer Inc, Prestige Brands Holdings Inc, Reckitt Benckiser Plc, Private-Label and Others......311
Pet Health Products......312
Table 307: Market Shares of Leading Pet Health Product Manufacturers in the US (2015) - Percentage Breakdown by Value for Bayer AG, Merial Ltd., Pfizer Ltd., and Others......312
Generic Pharmaceutical......313
Table 308: Market Shares of Leading Generic Pharmaceutical Companies by Value Sales in India (2014) - Percentage Breakdown for Abbott India Ltd., Alkem Laboratories Ltd., Cipla Ltd., GlaxoSmithKline Pharmaceuticals Ltd. (GSK), Lupin Ltd., Mankind Pharma, Pfizer Ltd., Ranbaxy Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Zydus Cadila and Others......313
Table 309: Market Shares of Leading Generics Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Ems Sigma Pharma Group, Eurofarma Laboratórios, Hypermarcas S.A., Pfizer, Inc., Sanofi - Medley Indústria Farmacêutica Ltda and Others......314
Table 310: Market Shares of Leading Branded Generic Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Cimed Indústria Farmacêutica Ltda, Ems Sigma Pharma Group, Hypermarcas S.A., Pfizer, Inc., Takeda Pharmaceutical Company Limited, União Química Farmacêutica Nacional S.A and Others......315
Prefilled Syringes......316
Table 311: Market Shares of Leading Prefilled Syringes Buyers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc (GSK), Novo Nordisk A/S (NVO), Pfizer, Inc. (PFE), Sanofi S.A., and Others......316
Alzheimer Disease Therapeutic......317
Table 312: Market Shares of Leading Alzheimer Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Forest Laboratories, Inc., Johnson & Johnson, Novartis International AG, Pfizer, Inc., and Others......317
Bone Diseases Therapeutic......318
Table 313: Market Shares of Leading Bone Diseases Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Amgen, Inc., Eli Lilly and Company, GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, Sanofi S.A., and Others......318
Infectious Disease Drugs......319
Table 314: Market Shares of Leading Infectious Disease Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol- Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......319
Rheumatology Therapeutic......320
Table 315: Market Shares of Leading Rheumatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......320
Urinary Incontinence Therapeutic......321
Table 316: Market Shares of Leading Urinary Incontinence Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Eli Lilly and Company, Johnson & Johnson, Novartis AG, Pfizer, Inc., and Others......321
Vitamins......322
Table 317: Market Shares of Leading Vitamin Manufacturers through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown by Value for Bausch & Lomb, Inc., Bayer AG, Church & Dwight Co., Inc., Pfizer, Inc., Reckitt Benckiser Group plc, and Others......322
Table 318: Market Shares of Leading Vitamins & Dietary Supplement Product Producers by Value Sales in the US (2014) - Percentage Breakdown for Bayer AG, General Nutrition Centres, Inc., GlaxoSmithKline Plc, Herbalife Ltd., Johnson & Johnson, Inc., Living Essentials, LLC, NBTY, Inc., Novartis AG, Otsuka Holdings Co., Ltd., Pfizer, Inc., Procter & Gamble Co., Private Label and Others......323
Table 319: Pfizer Ltd.’s Revenue by Category Worldwide (2013-2014) in Rupees Lakhs for Revenue from Operations (Gross), Other Operating Income and Other Income......324
Table 320: Pfizer, Inc.’s Sales by Business Segment Worldwide (2014-2015) in Percentage for Global Innovative Pharmaceuticals (GIP), Global Vaccines, Oncology and Consumer Healthcare (VOC), Global Established Pharmaceuticals (GEP), and Others......325
Table 321: Pfizer, Inc.’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for United States, Europe, and Others......326
Table 322: Pfizer, Inc.’s Sales by Product Segment Worldwide (2015) in Percentage for Innovative Products (Global Innovative Pharmaceuticals (GIP), and Global Vaccines, Oncology and Consumer Healthcare (VOC)), Global Established Pharmaceuticals (GEP) (Legacy Established Products, Peri-Loe Products, Sterile Injectable Pharmaceuticals, Infusion Systems, and Biosimilars), and Others......327
Table 323: Pfizer, Inc.’s Sales by Geographic Region Worldwide (2013) in Percentage for United States, Europe and Rest pof World......328
Table 324: Pfizer, Inc.’s Sales by Product Segment Worldwide (2011-2013) in US$ Million for Biopharmaceutical Products and Consumer Healthcare......329